Industry top-down
Medical Devices
Latest reported revenue & EPS across the covered companies in this industry, with year-over-year (YoY) change. From disclosed earnings — not investment advice.
AI industry top-down
The medical device industry generally experienced robust sales growth. Many companies recorded double-digit sales growth rates, reflecting the industry's vitality. However, individual company performance varied, with some firms experiencing a decline in EPS despite strong sales growth. Notably, EPS growth rates exhibited significant disparities across companies, indicating a mixed picture regarding profitability. While overall sales growth was positive, profitability metrics varied distinctly across companies.
- Most companies show robust revenue growth
- Some companies record high revenue growth rates
- Significant disparity in EPS growth rates across companies
AI synthesis of disclosed results and analyst research across these companies — not investment advice.
Companies — latest quarter
| Company | Period | Revenue | Rev YoY | EPS | EPS YoY | Surprise |
|---|---|---|---|---|---|---|
| ABTABBOTT LABORATORIES | FY2026 Q1 | $10.36B | +4.0% | $0.76 | +8.6% | — |
| SYKSTRYKER CORP | FY2026 Q1 | $5.87B | +11.9% | $1.69 | -17.6% | — |
| MDTMedtronic plc | FY2026 Q3 | $24.61B | +3.5% | $2.79 | +22.9% | — |
| BSXBOSTON SCIENTIFIC CORP | FY2026 Q1 | $4.66B | +20.9% | $0.45 | +36.4% | — |
| EWEdwards Lifesciences Corp | FY2026 Q1 | $1.41B | +6.2% | $0.61 | +5.2% | — |
| DXCMDEXCOM INC | FY2026 Q1 | $1.04B | +12.5% | $0.27 | -25.0% | — |
| GEHCGE HealthCare Technologies Inc. | FY2026 Q1 | $4.78B | +2.7% | $1.23 | +51.9% | — |
| PENPenumbra Inc | FY2026 Q1 | $324.14M | +16.3% | $1.00 | +257.1% | — |
| GMEDGLOBUS MEDICAL INC | FY2026 Q1 | $598.12M | -1.4% | $0.54 | — | — |
| PODDINSULET CORP | FY2026 Q1 | $569M | +28.8% | $0.50 | -31.5% | — |
| MASIMASIMO CORP | FY2026 Q1 | $372M | +9.5% | $-3.12 | — | — |
| BRKRBRUKER CORP | FY2026 Q1 | $801.4M | +11.0% | $0.11 | -68.6% | — |
| BIOBIO-RAD LABORATORIES, INC. | FY2026 Q1 | $585.4M | -4.2% | $2.29 | -83.0% | — |
| BIO-BBIO-RAD LABORATORIES, INC. | FY2026 Q1 | $585.4M | -4.2% | $2.29 | -83.0% | — |
| GKOSGLAUKOS Corp | FY2026 Q1 | $106.66M | +24.6% | $-0.32 | — | — |
| LIVNLivaNova PLC | FY2026 Q1 | $316.86M | +7.4% | $-6.01 | — | — |
| IRTCiRhythm Holdings, Inc. | FY2026 Q1 | $158.68M | +20.3% | $-0.97 | — | — |
| HAEHAEMONETICS CORP | FY2026 Q3 | $1.03B | +6.7% | $2.14 | +13.2% | — |
| ITGRInteger Holdings Corp | FY2026 Q1 | $437.39M | +7.3% | $-0.66 | — | — |
| AXGNAxogen, Inc. | FY2026 Q1 | $48.56M | +17.4% | $-0.08 | — | — |
| ESTAESTABLISHMENT LABS HOLDINGS INC. | FY2026 Q1 | $41.38M | +11.3% | $-0.70 | — | — |
| NVCRNovoCure Ltd | FY2026 Q1 | $154.99M | +11.9% | $-0.31 | — | — |
| NEOGNEOGEN CORP | FY2026 Q3 | $669.2M | -2.7% | $-2.21 | — | — |
| PRCTPROCEPT BioRobotics Corp | FY2026 Q1 | $69.16M | +55.3% | $-0.45 | — | — |
| ALMRAlamar Biosciences, Inc. | FY2026 Q1 | $13.09M | — | $-0.68 | — | — |
| AHCOAdaptHealth Corp. | FY2026 Q1 | $777.88M | -1.8% | $-0.05 | — | — |
| ENOVEnovis CORP | FY2026 Q1 | $558.83M | +8.2% | $-0.98 | — | — |
| IARTINTEGRA LIFESCIENCES HOLDINGS CORP | FY2026 Q1 | $382.65M | +3.7% | $-0.33 | — | — |
| INSPInspire Medical Systems, Inc. | FY2026 Q1 | $201.32M | +22.7% | $0.10 | — | — |
| BFLYButterfly Network, Inc. | FY2026 Q1 | $21.23M | +20.2% | $-0.06 | — | — |
YoY = vs. the same quarter last year · Surprise = EPS actual vs. consensus. Latest reported quarter per company, from disclosed earnings filings. QoQ is omitted because quarterly filings don’t break out Q4 (US) and report cumulatively (KR).